Indication
Osteosarcoma of bone
Osteosarcoma of bone is a primary malignant neoplasm of the skeletal system characterized by the direct production of osteoid or immature bone matrix by malignant mesenchymal cells. Read more about Osteosarcoma of bone
54 drugs 30 manufacturers
Drugs that treat it
Common Osteosarcoma of bone therapies.
METHOTREXATE SODIUM (methotrexate sodium/PF)
DOXORUBICIN (doxorubicin HCl)
METHOTREXATE SODIUM (PF) (methotrexate sodium/PF)
DOXORUBICIN HCL
DOXORUBICIN HCL
DOXORUBICIN HCL
METHOTREXATE SODIUM (methotrexate sodium/PF)
DOXORUBICIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOsteosarcoma of bone is a primary malignant neoplasm of the skeletal system characterized by the direct production of osteoid or immature bone matrix by malignant mesenchymal cells.
It exhibits a bimodal age distribution, most frequently arising during the adolescent and young adult growth spurt, with a secondary peak among older adults often linked to predisposing conditions such as Paget disease or prior irradiation.
The condition predominantly develops within the metaphyseal regions of long tubular bones, most commonly the distal femur, proximal tibia, and proximal humerus.
Clinically, it typically presents with localized, progressive bone pain and soft tissue swelling, with a marked propensity for cortical destruction and hematogenous metastasis, particularly to the lungs.
- nih.gov
Osteosarcoma of bone is a primary malignant neoplasm of the skeletal system characterized by the direct production of osteoid or immature bone matrix by malignant mesenchymal cells
- nih.gov
Osteosarcoma of bone is a primary malignant neoplasm of the skeletal system characterized by the direct production of osteoid or immature bone matrix by malignant mesenchymal cells
- nih.gov
It exhibits a bimodal age distribution, most frequently arising during the adolescent and young adult growth spurt, with a secondary peak among older adults often linked to predisposing conditions such as Paget disease or prior irradiation Clinically, it typically presents with localized, progressive bone pain and soft tissue swelling, with a marked propensity for cortical destruction and hematogenous metastasis, particularly to the lungs
- nih.gov
It exhibits a bimodal age distribution, most frequently arising during the adolescent and young adult growth spurt, with a secondary peak among older adults often linked to predisposing conditions such as Paget disease or prior irradiation The condition predominantly develops within the metaphyseal regions of long tubular bones, most commonly the distal femur, proximal tibia, and proximal humerus Clinically, it typically presents with localized, progressive bone pain and soft tissue swelling, wi...
- mayoclinic.org
Clinically, it typically presents with localized, progressive bone pain and soft tissue swelling, with a marked propensity for cortical destruction and hematogenous metastasis, particularly to the lungs
Personalize your experience
Follow Osteosarcoma of bone and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.